Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-055176

EVP & Chief Commercial Officer sold 220 shares at $88.00 ($19,360)

From the SEC's structured data for this filing

Trades in this filing

Harris Erik · EVP & Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-10-14 Sale : show line 1 in the form −220 $88.00 $19,360 23,370 D
Open-market sales · 220 sh · avg $88.00 · $19,360
Loading xslF345X03/doc4.xml…